News
Orexo announces termination of OX-CLI and OX-ESI programs
Orexo and Janssen Pharmaceuticals, formerly Ortho-McNeil-Janssen Pharmaceuticals, and Janssen Pharmaceutica, have terminated their research collaboration and license agreement regarding the OX-CLI and OX-ESI programs. A third, undisclosed Janssen program was also terminated. Each party has...
News
Precision receives US patent related to engineered meganucleases
Precision BioSciences has received US patent which covers claims related to methods of cleaving a target DNA site in a cell using an engineered meganuclease. These methods are broadly utilized as a part of Precision's...
News
Vanda reports positive data of tasimelteon in Non-24-Hour Disorder
Vanda Pharmaceuticals' tasimelteon has shown the ability to reset the body clock and to align it to a constant 24-hour day in patients suffering from Non-24-Hour Sleep-Wake Disorder (Non-24-Hour Disorder). Tasimelteon is a circadian...
News
Prosensa secures financing to develop RNA-modulating therapeutics
Dutch-based biopharmaceutical company, Prosensa has raised €23m in new equity financing to advance its portfolio of RNA-modulating therapeutics for the treatment of rare diseases, including Duchenne muscular dystrophy (DMD), Myotonic Dystrophy (DM1) and Huntington's disease (HD). ...
News
Selventa receives new patent for discovery of biomarker profiles
Selventa, a biomarker discovery company, has received US patent entitled Computer-aided Discovery of Biomarker Profiles in Complex Biological Systems. The patent is related to methods and techniques that facilitate discovery of biomarkers and aid in the...
News
Upsher-Smith launches new prenatal vitamin
Upsher-Smith Laboratories has launched B-Nexa, a prescription prenatal vitamin for pregnant women who suffer from nausea and vomiting of pregnancy (NVP). B-Nexa is designed with B vitamins and ginger to help calm NVP, also...
News
Merck will pay a maximum of $37 million to settle all claims against its painkiller Vioxx in Canada.
The settlement includes $10 million in costs and fees, and will total between $21.8 million and $37 million, depending upon the number of eligible claims. The plaintiffs’ lawyer Mike Peerless said up to 2,000 Canadians...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read